Effect of GnRH Agonist in FET

计划入组 122 人 · 首次发布于 2026 年 6 月 17 日

Safety of Oral Thrombopoietin Receptor Agonist in Pediatric Chronic ITP

计划入组 100 人 · 首次发布于 2023 年 5 月 6 日

mixed agonist -antagonist protocol

计划入组 300 人

GPR52 agonists(Takeda Pharmaceutical)

GPR52 agonists(Beacon Discovery/Boehringer Ingelheim Pharma)

GPR52 agonists(University of Texas Medical Branch)

Alturas Minerals Corp

United States

Crinetics

United States

PROGRAMME AGAINST MALNUTRITION

Zambia

Nxera Pharma Regains Rights to Phase 2-Ready Schizophrenia Drug After Boehringer Ingelheim Declines Licensing Option

Boehringer Ingelheim Expands Schizophrenia Pipeline with Sosei Heptares and Autifony Collaborations

Nxera Pharma Announces Strategic Restructuring with 15% Workforce Reduction to Focus on GPCR Pipeline